INOVIO to Participate in Upcoming Investor Conferences in May

Rhea-AI Summary

INOVIO, a biotechnology company specializing in DNA medicines for HPV-related diseases, cancer, and infectious diseases, will participate in various investor conferences in May. Dr. Jacqueline Shea, President & CEO, will represent the company in fireside chats at The Citizens JMP Life Sciences Conference, RBC Capital Markets 2024 Global Healthcare Conference, and H.C. Wainwright 2nd Annual BioConnect Investor Conference. The company aims to engage with investors through one-on-one meetings and webcasts available on their Investor Relations Events page.

PLYMOUTH MEETING, Pa., April 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that management will participate in the following investor conferences during the month of May:

The Citizens JMP Life Sciences Conference
Date: Tuesday, May 14, 2024
Time: 11:30 AM ET
Presenter: Dr. Jacqueline Shea, President & CEO
Format: Fireside Chat

RBC Capital Markets 2024 Global Healthcare Conference
Date: Wednesday, May 15, 2024
Time: 10:00 AM ET
Presenter: Dr. Jacqueline Shea, President & CEO
Format: Fireside Chat

H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
Date: Monday, May 20, 2024
Time: 12:30 PM ET
Presenter: Dr. Jacqueline Shea, President & CEO
Format: Fireside Chat

During the conferences, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors.

Webcasts of the fireside chats will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx. Replays of the webcasts will be available for 90 days after the date of the presentation.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-investor-conferences-in-may-302129665.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO participate in upcoming investor conferences?

INOVIO will participate in investor conferences in May, including The Citizens JMP Life Sciences Conference, RBC Capital Markets 2024 Global Healthcare Conference, and H.C. Wainwright 2nd Annual BioConnect Investor Conference.

Who will represent INOVIO at the conferences?

Dr. Jacqueline Shea, President & CEO of INOVIO, will represent the company at the investor conferences.

Where can I watch the webcasts of the fireside chats?

Webcasts of the fireside chats will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx.

How long will the replays of the webcasts be available?

Replays of the webcasts will be available for 90 days after the date of the presentation.